A robust R&D project portfolio optimization model for pharmaceutical contract research organizations
Year of publication: |
2014
|
---|---|
Authors: | Hassanzadeh, Farhad ; Modarres, Mohammad ; Nemati, Hamid R. ; Amoako-Gyampah, Kwasi |
Published in: |
International journal of production economics. - Amsterdam [u.a.] : Elsevier, ISSN 0925-5273, ZDB-ID 1092526-0. - Vol. 158.2014, p. 18-27
|
Subject: | Pharmaceutical contract research organization (CRO) | Research and Development (R&D) | Project selection and scheduling | Uncertainty | Robust optimization | Projektmanagement | Project management | Theorie | Theory | Industrieforschung | Industrial research | Pharmaindustrie | Pharmaceutical industry | Portfolio-Management | Portfolio selection | Forschung | Research | Mathematische Optimierung | Mathematical programming | Pharmakologie | Pharmacology | Robustes Verfahren | Robust statistics | Vertrag | Contract |
-
Research and development in the chemical and pharmaceutical industry
Bamfield, Peter, (2006)
-
Rival signals and project selection : insights from the drug development process
Markou, Panos, (2023)
-
Realoptionen als Controlling-Instrument : das Beispiel pharmazeutische Forschung und Entwicklung
Pritsch, Gunnar, (2000)
- More ...
-
A robust R&D project portfolio optimization model for pharmaceutical contract research organizations
Hassanzadeh, Farhad, (2014)
-
Hassanzadeh, Farhad, (2014)
-
A robust optimization approach to R&D portfolio selection
Hassanzadeh, Farhad, (2009)
- More ...